ArticleBioengineered2022

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.

Xuemei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.